Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy

BACKGROUND AND AIMS: A similar course of COVID-19 in patients with inflammatory bowel diseases (IBD) and in the general population has been reported. However, disease prevalence in IBD patients is presently unknown. In this prospective observational study we aimed at determining SARS-CoV2 infection...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Crohns Colitis
Main Authors: Berte', Roberto, Mazza, Stefano, Stefanucci, Marta Rachele, Noviello, Daniele, Costa, Stefania, Ciafardini, Clorinda, Mileti, Erika, Mapelli, Marina, Pasqualato, Sebastiano, Pinto, Sergio, Favale, Agnese, Vecchi, Maurizio, Neurath, Markus F, Atreya, Raja, Fantini, Massimo Claudio, Facciotti, Federica, Caprioli, Flavio
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717179/
https://ncbi.nlm.nih.gov/pubmed/33211810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados